Aortic Dissection

Cardiovascular
0
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Shape Memory Medical
3 programs
False Lumen Embolization System, IMPEDE-FX RapidFillN/A1 trial
False Lumen Embolization System, IMPEDE-FX RapidFillN/A1 trial
False Lumen Embolization System, IMPEDE-FX RapidFillN/A1 trial
Active Trials
NCT06550986Not Yet RecruitingEst. Feb 2029
NCT07387250Not Yet RecruitingEst. Apr 2029
NCT06740721Not Yet RecruitingEst. Jan 2029
Artivion
ArtivionKENNESAW, GA
1 program
AMDSN/A1 trial
Active Trials
NCT03035643CompletedEst. Mar 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
Shape Memory MedicalFalse Lumen Embolization System, IMPEDE-FX RapidFill
Shape Memory MedicalFalse Lumen Embolization System, IMPEDE-FX RapidFill
Shape Memory MedicalFalse Lumen Embolization System, IMPEDE-FX RapidFill
ArtivionAMDS

Clinical Trials (4)

NCT06740721Shape Memory MedicalFalse Lumen Embolization System, IMPEDE-FX RapidFill

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA)

Start: Oct 2026Est. completion: Jan 2029
N/ANot Yet Recruiting
NCT07387250Shape Memory MedicalFalse Lumen Embolization System, IMPEDE-FX RapidFill

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL)

Start: Apr 2026Est. completion: Apr 2029
N/ANot Yet Recruiting
NCT06550986Shape Memory MedicalFalse Lumen Embolization System, IMPEDE-FX RapidFill

False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study

Start: Feb 2026Est. completion: Feb 2029
N/ANot Yet Recruiting
NCT03035643ArtivionAMDS

DARTS I Feasibility Study

Start: Mar 2017Est. completion: Mar 2024
N/ACompleted

Related Jobs in Cardiovascular

Embedded Software and System Test Engineer (H/F)

Cardiawave
Levallois-Perret, France (Hybrid)
Just now

Territory Sales Manager - Iowa / Nebraska

HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
23h ago
From $150K/yr

Physician Program Director, Los Angeles

Johnson & Johnson
Danvers, Massachusetts, United States of America
Yesterday
$132K - $212K/yr

J&J MedTech Neurovascular Senior Financial Analyst, R&D

Johnson & Johnson
Irvine, California, United States of America
Yesterday
$79K - $128K/yr

Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90

Johnson & Johnson
Issy-les-Moulineaux, France
Yesterday

Trainee Technical Specialist

Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Heart Failure(334)Hypertension(333)Coronary Artery Disease(295)Atrial Fibrillation(288)Pulmonary Arterial Hypertension(103)Acute Coronary Syndrome(62)Pulmonary Hypertension(55)Essential Hypertension(32)Coronary Heart Disease(28)Aortic Valve Stenosis(27)